Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

A real-world, cross-sectional, and longitudinal study on high-risk human papillomavirus genotype distribution in 31,942 women in Dongguan, China

Bibliographic Data

ID22076819
AuthorsHuanxia Zhong (Dongguan People’s Hospital), Wenwei Pan (Dongguan People’s Hospital), Binbin Chen (0000-0001-5962-3147, BGI Group (China)), Jiamin Gu (0000-0001-6231-0619, Dongguan People’s Hospital), Liang Yu (0000-0002-4597-885X, Dongguan People’s Hospital), Yu Liang (0009-0002-8666-8046), Guoli Sun (0000-0001-8888-379X, Dongguan People’s Hospital), Xinghua Huang (0000-0003-3049-100X, Dongguan People’s Hospital), Huitao Yuan (Dongguan People’s Hospital), Haina Guo, H N Guo (0000-0003-4386-7854, Dongguan People’s Hospital), Ling Zhong (0000-0002-0196-4587, Dongguan People’s Hospital), Zhuanfen Li (Dongguan People’s Hospital), Ping Zhou (0000-0003-1974-4424, Dongguan People’s Hospital, corresponding author), Zhou Ping (0000-0001-5471-5261), Siliang Zeng (0009-0002-5863-8659, Dongguan People’s Hospital, corresponding author), Li Tang (0000-0001-8311-2507, Dongguan People’s Hospital, corresponding author)
Year2024
Volume12
Pages1409030-1409030
Publication date2024-08-01
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2024.1409030
PMID39148652
OpenAlexW4401218280
LanguageEN
References cited27

Background Persistent human papillomavirus (HPV) infection remains a key risk factor for cervical cancer. HPV-based primary screening is widely recommended in clinical guidelines, and further longitudinal studies are needed to optimize strategies for detecting high-grade cervical lesions compared to cytology. Methods From November 2015 to December 2023, 31,942 participants were included in the real-world observational study. Among those, 4,219 participants underwent at least two rounds of HPV tests, and 397 completed three rounds of HPV tests. All participants were tested for high-risk types of HPV 16/18/31/33/35/39/45/51/52/56/58/59/66/68 (hrHPV) and low-risk types of HPV6/11 genotyping. Some participants also received cytology or colposcopy with pathology. Results In the cross-sectional cohort, the prevalence of hrHPV and all HPV subtypes was 6.6% (2,108/31,942) and 6.8% (2,177/31,942), respectively. The three top hrHPV genotypes were HPV52 (1.9%), HPV58 (0.9%), and HPV16 (0.9%). Age distributions showed two peaks at 45–49 and 60–65 years. For the primary screening cohort, the hrHPV prevalence rate increased from 4.8% in 2015–2017 to 7.0% in 2020–2020 and finally reached 7.2% in 2023. For the longitudinal cohort study, the hrHPV prevalence rates in the repeated population (3.9, 5.3, and 6.0%) were lower than the primary hrHPV screening rates (6.6%), which indicated that repeated screening might decrease the prevalence rate. Methodologically, the hrHPV (89.5%) and the screening group of 16 subtypes (92.3%) demonstrated superior sensitivity than the cytology group (54.4%). Moreover, the longitudinal study indicated that the persistent hrHPV subgroup had a significantly higher ( p = 0.04) incidence of high-grade squamous intraepithelial lesions and more histology progression events (7/17 vs. 0/5) than the reinfection group. Conclusion The study indicates a rising high-risk HPV prevalence in Dongguan, with repeated screening reducing this trend. The findings support HPV-based primary screening and might guide HPV vaccination and cervical cancer prevention in South China

Biology · China · Cross-sectional study · Environmental health · Gene · Genotype · Geography · Human papillomavirus · Pathology · Sociology · Cervical Cancer and HPV Research · Demography · Head and Neck Cancer Studies · Mathematics · Medicine · Reproductive tract infections research · Genetics · Internal Medicine · Virology

  • Global estimates of incidence and mortality of cervical cancer in 2020

    Open Access•Deependra Singh, Jerome Vignat et al.•The Lancet Global Health•2023

  • Global Cancer Statistics 2020

    Open Access•Hyuna Sung, Adalberto M Filho et al.•CA: A Cancer Journal for Clinicians•2021

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae